Phase II Study of Binimetinib in Children and Adults With NF1 Plexiform Neurofibromas

NCT03231306 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

45

Enrollment

OTHER

Sponsor class

Conditions

Neurofibromatosis Type 1
Plexiform Neurofibroma

Interventions

DRUG: Binimetinib

Sponsor

University of Alabama at Birmingham

Collaborators

[object Object]
[object Object]